Skip to content

It looks like we may have content for your preferred language. Would you like to view this page in English?

American Conference Institute’s (ACI) Summit on Biosimilars & Innovator Biologics

Loeb & Loeb LLP is proud to announce that Partner, Ryan Hagglund, will be speaking during American Conference Institute’s (ACI) Biosimilars & Innovator Biologics Summit from June 20-21, 2024 on the panel "Reference Drug Patent Challenges: Unpacking Recent IPR Decisions and Insights" on June 21.

From the event website:
This event brings together leaders from both biosimilar and innovator biologic industries. Attendees gain practical insights and learn the most advanced strategies to overcome hurdles in the three critical pillars of this industry: Legal, Regulatory, and Commercialization.

For more information, including how to register, please visit the event website.